Our website uses cookies to make navigation as functional as possible. Our cookies do not enable us to identify you in any way. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here to disable them. By continuing to browse this site , you will be accepting our cookies.



Dear Colleagues 

The University Hospital Zurich has a long tradition in pioneering research and developments in cardiovascular medicine. Indeed, in the sixties the renowned cardiac surgeon Ake Senning established one of the first cardiac surgery departments in Zurich. Besides the worldwide first implantation of a pacemaker, he developed new surgical techniques and procedures particularly for patients with congenital heart disease. Furthermore, in 1977 Andreas Grüntzig successfully performed in Zurich the first percutaneous coronary intervention with a balloon catheter he had developed. His seminal intervention has become one of the most frequently performed procedures in patients with coronary disease and opened the door for interventions in structural heart disease. The current department has continued this tradition and contributed substantially to the understanding and management of atherosclerotic vascular disease and heart failure. On the background of these historic milestones in cardiovascular medicine, it is our great pleasure to continue this tradition as a center of excellence in cardiovascular medicine and to invite you to the preceptorship programme on hot topics in cardiology in Zurich. The programme will focus on special areas with most recent therapeutic advances and innovations including risk factors and cardiovascular prevention, angina and acute coronary syndromes, atrial fibrillation, valve disease and heart failure. A distinguished international teaching faculty will contribute to an outstanding programme on the latest scientific and therapeutic developments in the respective areas. The educational objectives are to provide a comprehensive update on new diagnostic approaches, clinical trials and treatment modalities. State of the art lectures will be illustrated with demonstrations of patient cases, round table discussions and video life cases for interventional valve procedures. A particular emphasis will be placed on chronic and acute heart failure, the new epidemic of the 21st century. Cardiovascular clinicians, internists, and primary care physicians attending will derive benefit from this three-day preceptorship course with the goal to better serve their patients. We are looking forward to welcoming you in Zurich and spending a stimulating meeting together. 

Thomas F. Lüscher,
MD, FRCP, FESC Professor and Chairman of Cardiology

Reserved area

Minuti Menarini Online

Beside the Scientific Edition, Fondazione Menarini edits the publication of the Artistic Edition of "Minuti Menarini" addressed to all Italian doctors who love art

SIGN UP FOR THE NEWSLETTER

Receive information about the Fondazione Internazionale Menarini every month.

Sign Up

Fad

Recent advances in understanding and treating chronic myeeloid neoplasms

FAD Course: total of 6 ECM credits

Duration: 20 May 2017 - 20 May 2018
Target: 15.000 partecipants. Anatomia patologica, Ematologia, Genetica medica, Laboratorio di genetica medica, Medicina interna, Medicina trasfusionale, Oncologia, Tecnico sanitario laboratorio biomedico e per Biologo - Farmacista ospedaliero - Infermiere.

The KIDNEY, HYPERTENSION and CARDIOVASCULAR RISK

CORSO FAD: un totale di 13 crediti ECM

Durata: 1 Maggio 2017 - 30 Aprile 2018
Target: Medico Chirurgo, Medici di Famiglia

Per maggiori informazioni visita il sito: www.cvrisk.it

Fondazione Internazionale Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484